Heteroaromatic compounds for use as HIF inhibitors

Details for Australian Patent Application No. 2009315930 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Harter, Michael; Beck, Hartmut; Ellinghaus, Peter; Berhoerster, Kerstin; Greschat, Susanne; Thierauch, KarlHeinz; Sussmeier, Frank

Agent Davies Collison Cave

Pub. Number AU-A-2009315930

PCT Pub. Number WO2010/054764

Priority 10 2009 041 241.7 11.09.09 DE; 10 2008 057 364.7 14.11.08 DE

Filing date 31 October 2009

Wipo publication date 20 May 2010

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/054764 Priority application(s): WO2010/054764

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009315974-Asymmetrical mounting

2009315919-Crossed structure magnetic separator with tetrapolar rotary magnetic circuit and annular rotors